Digitally Supported Short-Term Prehabilitation Before Total Knee Replacement (P2R-KneeTEP)

Prehab2Rehab: Digitally Supported Short-Term Prehabilitation Before Total Knee Replacement - A Randomized Controlled Feasibility Trial

This study evaluates the feasibility of a short-term, digitally supported prehabilitation program for patients scheduled for elective total knee replacement (TKR). Osteoarthritis is a leading cause of disability, and recovery following TKR remains heterogeneous, with a substantial proportion of patients experiencing delayed functional recovery. Prehabilitation may improve perioperative outcomes, but its implementation is often limited by short preoperative time windows.

The Prehab2Rehab-KneeTEP trial is a single-center, two-arm, randomized controlled feasibility study conducted in Austria. Patients will be randomized (1:1) to either a multimodal video-supported prehabilitation program or usual care. The intervention consists of a 10 to 14-day preoperative exercise program including strength, endurance, coordination, and gait training, supported by a digital application, and is complemented by a digitally supported transition phase after hospital discharge until the start of inpatient rehabilitation.

The primary objective is to assess feasibility in terms of recruitment, retention, adherence, fidelity, acceptability, and safety. Secondary exploratory outcomes include clinical recovery indicators, functional performance, and patient-reported outcomes assessed across the perioperative pathway.

Study Overview

Detailed Description

Total knee replacement (TKR) is an effective treatment for advanced knee osteoarthritis, yet postoperative recovery remains heterogeneous, with a substantial proportion of patients experiencing persistent functional limitations. Prehabilitation has the potential to optimize patients' physical and psychological readiness before surgery. However, in clinical practice, prehabilitation is often constrained by limited time between surgical indication and procedure. Digitally supported interventions may offer a feasible solution to deliver structured programs within short timeframes while supporting continuity of care across the perioperative pathway.

The Prehab2Rehab-KneeTEP trial is a single-center, randomized, two-arm feasibility study conducted at the Medizinisches Zentrum Bad Vigaun, Austria. The study aims to evaluate the feasibility, acceptability, and safety of a short-term, digitally supported prehabilitation intervention in patients scheduled for elective TKR.

Eligible patients with advanced knee osteoarthritis will be randomized in a 1:1 ratio following baseline assessment (PRE1) to either (i) a multimodal video-supported prehabilitation intervention with an additional digitally supported transition phase or (ii) usual care. Randomization will be performed using computer-generated permuted blocks with stratification for sex and baseline functional capacity assessed by the 6-minute walk test.

The intervention consists of a 10 to 14-day prehabilitation phase prior to surgery, including endurance, resistance, coordination, and gait training. The program is delivered through a combination of in-person instruction and home-based training supported by a digital application (aktivplan), which provides structured exercise guidance and enables documentation of adherence. A teleconsultation via a secure video platform (CAATS) is conducted to ensure exercise safety, provide feedback, and support progression. Sensor-based systems may be used for documentation and research-related measurements but are not used for clinical decision-making.

Following surgery and hospital discharge, participants in the intervention group enter a digitally supported transition phase lasting approximately 10 to 14 days until the start of inpatient rehabilitation (REH1). During this period, patients receive low-threshold exercise guidance and educational content via the digital application to support early recovery, maintain mobility, and promote self-efficacy. Participants in both groups receive standard surgical care and standardized inpatient rehabilitation according to institutional and national guidelines.

The total study participation duration is approximately 47 to 61 days, covering prehabilitation, hospital stay, transition, and rehabilitation phases. Outcomes are assessed at predefined time points along the perioperative pathway, including baseline (PRE1), end of prehabilitation (PRE2), hospital discharge, start of rehabilitation (REH1), and end of rehabilitation (REH2).

The primary objective is to assess feasibility across multiple domains, including recruitment, retention, adherence, fidelity, acceptability, usability of digital tools, and safety. Feasibility outcomes will be evaluated descriptively across process, resource, management, and participant engagement domains.

Secondary objectives are exploratory and include the assessment of clinical recovery indicators such as length of hospital stay, complication rate, and readmission rate, as well as patient-reported outcomes, anthropometric and body composition parameters, and functional performance measures. Given the feasibility nature of the trial, analyses will be descriptive and hypothesis-generating, without confirmatory statistical testing.

The findings of this study will inform the design and implementation of a future adequately powered randomized controlled trial evaluating the effectiveness of digitally supported prehabilitation in patients undergoing total knee replacement

Study Type

Interventional

Enrollment (Estimated)

60

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

    • State of Salzburg
      • Hallein, State of Salzburg, Austria, 5424
        • Medizinisches Zentrum Bad Vigaun GmbH & Co. KG
        • Contact:
        • Contact:
        • Principal Investigator:
          • Hildebert Hutt, Prim. Dr.
        • Principal Investigator:
          • Thomas Hofstädter, Prim. Dr.
        • Sub-Investigator:
          • Josef Sturm, Dr.

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

Eligibility will be determined during the outpatient consultations at the Medical

Center in Bad Vigaun. Patients will be screened against the following criteria:

  • Age ≥18 years at the time of enrolment.
  • Clinically diagnosed with advanced osteoarthritis and with a medical indication for elective TKR.
  • Either a scheduled surgery or a documented intention to undergo TKR within the recruitment period.
  • Elective surgery is scheduled for at least 14 days after enrolment to allow completion of the 10 to 14-day prehabilitation intervention.
  • Physical ability to safely perform the prescribed exercise program, as confirmed by the treating physician.
  • Willingness to participate in a digitally supported training intervention at either the center or home-based.
  • Sufficient digital literacy and access to internet-enabled devices (smartphone, tablet, or computer).
  • Adequate German language proficiency to follow exercise instructions and study procedures.

Exclusion Criteria:

Patients will be excluded if any of the following apply:

  • Pregnancy at the time of enrolment.
  • Emergency, revisional, or non-elective surgery.
  • Surgery scheduled less than 14 days after enrolment.
  • Severe physical impairment or medical contraindication to exercise training (e.g., unstable cardiovascular disease, uncontrolled hypertension, acute musculoskeletal injury).
  • Patients with contraindications outlined in the Medizinisches Leistungsprofil (MLP) 2.0 that preclude rehabilitation and/or surgery.
  • Participation in another clinical study that could interfere with the intervention or study outcomes.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: Usual care
Usual Care (Control). Participants receive standard preoperative, surgical, and postoperative care including standard inpatient rehabilitation without prehabilitation or digital support.
Participants allocated to the usual care group will receive the standard perioperative treatment provided at the study site. This includes preoperative consultation, elective total knee replacement surgery according to institutional standards, and routine postoperative care. After hospital discharge, participants return home until the start of standardized inpatient rehabilitation (Phase II), including interdisciplinary care such as physiotherapy, occupational therapy, medical supervision, and health education. No structured prehabilitation or digitally supported intervention will be provided.
Other Names:
  • Usual Care Control Group
Experimental: Multimodal Video-Supported Prehabilitation
Multimodal Video-Supported Prehabilitation plus Digitally Supported Transition. Participants receive a 10 to 14-day multimodal prehabilitation program including endurance, resistance, coordination, and gait training, supported by the aktivplan application, one teleconsultation via CAATS, and research sensors for documentation. Digital support continues during the early post-discharge transition phase with low-threshold exercises and educational content until inpatient rehabilitation begins.
A short-term multimodal, video-supported prehabilitation program delivered over 10 to 14 days before surgery, including endurance, resistance, coordination, and gait training with crutches. The intervention is introduced during an in-person session and subsequently performed at home using a digital application to provide structured exercise guidance and support adherence. A single teleconsultation is conducted to ensure safety, provide feedback, and allow individualized progression. In addition, digital support is extended into the early post-discharge transition phase, providing low-threshold exercise guidance and educational content to support mobility, self-efficacy, and continuity of care until the start of inpatient rehabilitation.
Other Names:
  • Multimodal Prehabilitation Program

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Recruitment rate
Time Frame: Continuous throughout the recruitment period (12 months recruitment period)
The recruitment rate will be calculated as the percentage of eligible patients who consent to participate in the study. The reported value will be: (number of enrolled participants / number of eligible patients) × 100%.
Continuous throughout the recruitment period (12 months recruitment period)
Retention Rate
Time Frame: Continuous throughout the data collection period (14 months data collection period)
Retention will be measured as the percentage of enrolled participants who complete all required study procedures. The reported value will be: (number of participants completing the study / number of enrolled participants) × 100%.
Continuous throughout the data collection period (14 months data collection period)
Adherence to the Intervention
Time Frame: During the intervention period (typically 2-4 weeks prior to surgery).
Adherence will be defined as the proportion of prescribed prehabilitation sessions that participants complete. The reported value will be: (number of completed sessions / number of prescribed sessions) × 100%.
During the intervention period (typically 2-4 weeks prior to surgery).
Completeness of Outcome Data
Time Frame: Continuous throughout data collection period (14 months)
Completeness of data will be assessed as the percentage of planned outcome assessments that are successfully completed and available for analysis. The reported value will be: (number of completed assessments / number of planned assessments) × 100%.
Continuous throughout data collection period (14 months)
Acceptability of the Intervention
Time Frame: At discharge from inpatient rehabilitation (REH2, approximately 6 to 8 weeks after surgery)
Acceptability and usability of the digital intervention will be assessed using the mHealth App Usability Questionnaire (MAUQ). The MAUQ evaluates usability, satisfaction, ease of use, and perceived usefulness of mobile health applications. Items are rated on a 7-point Likert scale, ranging from 1 = strongly disagree to 7 = strongly agree. The outcome will be reported as the mean MAUQ score across completed questionnaires, with higher scores indicating greater perceived usability and acceptability.
At discharge from inpatient rehabilitation (REH2, approximately 6 to 8 weeks after surgery)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Health Assessment Questionnaire (HAQ)
Time Frame: Baseline, prehabilitation discharge (10-14 days after baseline, before surgery), rehabilitation admission (3-4 weeks after surgery), rehabilitation discharge (6-8 weeks after surgery).
Patient-reported outcome assessing functional ability in activities of daily living using the HAQ score. The instrument captures disability across multiple domains including dressing, arising, eating, walking, hygiene, reach, grip, and common daily activities. Total HAQ scores range from 0 to 3, with higher scores indicating greater functional impairment and lower functional status. The HAQ is used to evaluate changes in patient-reported functional status across the perioperative pathway.
Baseline, prehabilitation discharge (10-14 days after baseline, before surgery), rehabilitation admission (3-4 weeks after surgery), rehabilitation discharge (6-8 weeks after surgery).
Barthel-Index (BI)
Time Frame: Baseline (prior to intervention), admission to inpatient rehabilitation (3-4 wk post-surgery), discharge from inpatient rehabilitation (6-8 wk post-surgery)
Observer-based outcome assessing functional independence in activities of daily living using the Barthel Index (BI). The instrument evaluates performance in domains including feeding, bathing, grooming, dressing, bowel and bladder control, toilet use, transfers, mobility, and stair use. Total BI scores range from 0 to 100, with higher scores indicating greater functional independence and lower dependency. The BI is used to evaluate changes in functional independence across the perioperative pathway.
Baseline (prior to intervention), admission to inpatient rehabilitation (3-4 wk post-surgery), discharge from inpatient rehabilitation (6-8 wk post-surgery)
Oxford Knee Score (OKS)
Time Frame: Baseline (prior to intervention) and discharge from inpatient rehabilitation (6-8 wk post-surgery)
Patient-reported outcome assessing knee-specific pain and functional status using the OKS score. The instrument captures difficulties in activities such as walking, standing, and rising from a seated position. Scores are calculated according to standard OKS procedures, with higher values indicating better knee function and lower symptom burden. The OKS is used to evaluate changes in knee-related symptoms and function across the perioperative pathway.
Baseline (prior to intervention) and discharge from inpatient rehabilitation (6-8 wk post-surgery)
Patient Health Questionnaire-4 (PHQ-4)
Time Frame: Baseline (prior to intervention), after completion of prehabilitation (10-14 d after baseline, prior to surgery), admission to inpatient rehabilitation (3-4 wk post-surgery), discharge from inpatient rehabilitation (6-8 wk post-surgery)
Patient-reported outcome assessing symptoms of anxiety and depression (PHQ-4). Total score ranges from 0 to 12, with higher values indicating greater psychological distress. Used to monitor changes in psychological well-being across the perioperative pathway.
Baseline (prior to intervention), after completion of prehabilitation (10-14 d after baseline, prior to surgery), admission to inpatient rehabilitation (3-4 wk post-surgery), discharge from inpatient rehabilitation (6-8 wk post-surgery)
Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC)
Time Frame: Baseline (prior to intervention), admission to inpatient rehabilitation (3-4 wks post-surgery), discharge from inpatient rehabilitation (6-8 wks post-surgery).
Patient-reported outcome assessing knee pain, stiffness, and physical function (WOMAC). Higher scores indicate worse symptoms and functional limitations. Used to evaluate changes across the perioperative rehabilitation pathway.
Baseline (prior to intervention), admission to inpatient rehabilitation (3-4 wks post-surgery), discharge from inpatient rehabilitation (6-8 wks post-surgery).
EuroQol-5 Dimensions-5 Levels (EQ- 5D-5L)
Time Frame: Baseline (prior to intervention), after prehab intervention (10-14 d after baseline)), discharge (6-12 d post-surgery), admission to inpatient rehabilitation (3-4 wk post-surgery), discharge from inpatient rehabilitation (6-8 wk post-surgery).
The EuroQol-5 Dimensions-5 Levels (EQ-5D-5L) is a standardized, patient-reported outcome measure assessing health-related quality of life across five dimensions: mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. Each dimension is rated on five levels of severity. Responses are converted into a health utility index score, with higher values indicating better health status. The instrument also includes a visual analogue scale (EQ-VAS), ranging from 0 to 100, with higher scores indicating better self-rated health.
Baseline (prior to intervention), after prehab intervention (10-14 d after baseline)), discharge (6-12 d post-surgery), admission to inpatient rehabilitation (3-4 wk post-surgery), discharge from inpatient rehabilitation (6-8 wk post-surgery).
Rapid Assessment of Physical Activity (RAPA)
Time Frame: Baseline (prior to intervention), and discharge from inpatient rehabilitation (6-8 wks post-surgery).
Self-reported questionnaire assessing level of physical activity (RAPA). Scores reflect engagement in aerobic and strength-based physical activity, with higher scores indicating higher activity levels. Used to evaluate changes in physical activity behavior across the perioperative pathway.
Baseline (prior to intervention), and discharge from inpatient rehabilitation (6-8 wks post-surgery).
Exercise Self-Efficacy Scale (ESES)
Time Frame: Baseline (prior to intervention), after prehab intervention (10-14 d after baseline), discharge (6-12 d post-surgery), discharge from inpatient rehabilitation (6-8 wks post-surgery).
Exercise Self-Efficacy Scale (ESES). Self-reported measure assessing confidence in the ability to perform and maintain physical activity. Total scores range from 10 to 40, with higher scores indicating greater exercise self-efficacy and therefore a better outcome. Used to evaluate changes in exercise-related confidence across the perioperative pathway.
Baseline (prior to intervention), after prehab intervention (10-14 d after baseline), discharge (6-12 d post-surgery), discharge from inpatient rehabilitation (6-8 wks post-surgery).
Body Fat Mass
Time Frame: Baseline (prior to intervention) and discharge from inpatient rehabilitation (6-8 wk post-surgery).
Body fat mass measured using bioelectrical impedance analysis (BIA). Body fat mass represents the total amount of body fat and will be reported in kilograms (kg).
Baseline (prior to intervention) and discharge from inpatient rehabilitation (6-8 wk post-surgery).
Body Lean Mass
Time Frame: Baseline (prior to intervention) and discharge from inpatient rehabilitation (6-8 wk post-surgery).
Body Lean Mass measured using bioelectrical impedance analysis (BIA). Body Lean Mass represents the total amount of non-fat body tissue and will be reported in kilograms (kg).
Baseline (prior to intervention) and discharge from inpatient rehabilitation (6-8 wk post-surgery).
Phase Angle
Time Frame: Baseline (prior to intervention) and discharge from inpatient rehabilitation (6-8 wk post-surgery).
Phase angle measured using bioelectrical impedance analysis (BIA). Phase angle is a marker of cellular integrity and body cell mass and will be reported in degrees (°).
Baseline (prior to intervention) and discharge from inpatient rehabilitation (6-8 wk post-surgery).
6-Minute Walk Test (6MWT)
Time Frame: Baseline (prior to intervention), admission to inpatient rehabilitation (3-4 wks post-surgery), discharge from inpatient rehabilitation (6-8 wks post-surgery).
The 6-Minute Walk Test (6MWT) is used to assess functional exercise capacity. Participants are instructed to walk as far as possible for six minutes along a standardized corridor, with distance covered recorded in meters. Standardized instructions and encouragement are provided according to established guidelines.
Baseline (prior to intervention), admission to inpatient rehabilitation (3-4 wks post-surgery), discharge from inpatient rehabilitation (6-8 wks post-surgery).
Timed Up and Go Test (TUG)
Time Frame: Baseline (prior to intervention), after prehab intervention (10-14 d after baseline), admission to inpatient rehabilitation (3-4 wk post-surgery), discharge from inpatient rehabilitation (6-8 wk post-surgery).
The Timed Up and Go Test (TUG) assesses functional mobility. Participants are instructed to stand up from a seated position, walk a short distance, turn, return, and sit down, with the total time recorded in seconds under standardized conditions.
Baseline (prior to intervention), after prehab intervention (10-14 d after baseline), admission to inpatient rehabilitation (3-4 wk post-surgery), discharge from inpatient rehabilitation (6-8 wk post-surgery).
Single-Leg Stance (SLS)
Time Frame: Baseline (prior to intervention), after prehab intervention (10-14 d after baseline), admission to inpatient rehabilitation (3-4 wk post-surgery), discharge from inpatient rehabilitation (6-8 wk post-surgery).
The Single-Leg Stance (SLS) test assesses static balance. Participants are instructed to stand on one leg for as long as possible under standardized conditions, with time recorded in seconds.
Baseline (prior to intervention), after prehab intervention (10-14 d after baseline), admission to inpatient rehabilitation (3-4 wk post-surgery), discharge from inpatient rehabilitation (6-8 wk post-surgery).
Fifteen-meter Gait Analysis with crutches (15-mGA+)
Time Frame: Baseline (prior to intervention), after prehab intervention (10-14 d after baseline), admission to inpatient rehabilitation (3-4 wk post-surgery).
The Fifteen-meter Gait Analysis with crutches (15-mGA+) assesses gait performance under assisted walking conditions. Participants walk a standardized distance of 15 meters using crutches, with performance recorded under standardized conditions.
Baseline (prior to intervention), after prehab intervention (10-14 d after baseline), admission to inpatient rehabilitation (3-4 wk post-surgery).
Ten-meter Walk Test without crutches (10-mWT)
Time Frame: Baseline (prior to intervention), after prehab intervention (10-14 d after baseline), discharge from inpatient rehabilitation (6-8 wk post-surgery).
The Ten-meter Walk Test without crutches (10-mWT) assesses gait speed. Participants are instructed to walk a standardized distance of 10 meters without assistive devices, with time recorded under standardized conditions.
Baseline (prior to intervention), after prehab intervention (10-14 d after baseline), discharge from inpatient rehabilitation (6-8 wk post-surgery).
Knee Range of Motion (ROM)
Time Frame: Baseline (prior to intervention), discharge (6-12 d post-surgery), admission to inpatient rehabilitation (3-4 wks post-surgery), discharge from inpatient rehabilitation (6-8 wks post-surgery).
Knee Range of Motion (ROM) assesses joint mobility. Range of motion of the knee joint is measured in degrees under standardized conditions.
Baseline (prior to intervention), discharge (6-12 d post-surgery), admission to inpatient rehabilitation (3-4 wks post-surgery), discharge from inpatient rehabilitation (6-8 wks post-surgery).
Lower limb strength (LLS)
Time Frame: Baseline (prior to intervention), after prehab intervention (10-14 d after baseline), admission to inpatient rehabilitation (3-4 wk post-surgery), discharge from inpatient rehabilitation (6-8 wk post-surgery).
Lower limb strength (LLS) assesses muscular strength of the lower extremities. Strength is measured using an isokinetic dynamometer (Biodex) under standardized conditions.
Baseline (prior to intervention), after prehab intervention (10-14 d after baseline), admission to inpatient rehabilitation (3-4 wk post-surgery), discharge from inpatient rehabilitation (6-8 wk post-surgery).
Handgrip strength (HG)
Time Frame: Baseline (prior to intervention) and discharge from inpatient rehabilitation (6-8 wk post-surgery).
Handgrip strength (HG) assesses upper limb muscle strength using a handheld dynamometer under standardized conditions.
Baseline (prior to intervention) and discharge from inpatient rehabilitation (6-8 wk post-surgery).

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Unified Theory of Acceptance and Use of Technology (UTAUT-2)
Time Frame: At the discharge from inpatient rehabilitation (6-8 wk post-surgery).
Assesses user acceptance and behavioral intention to use digital health technologies, including perceived usefulness, ease of use, and facilitating conditions.
At the discharge from inpatient rehabilitation (6-8 wk post-surgery).
mHealth App Usability Questionnaire (MAUQ)
Time Frame: At the discharge from inpatient rehabilitation (6-8 wk post-surgery).
Usability of the digital intervention will be assessed MAUQ, a validated instrument designed to evaluate usability, ease of use, and satisfaction with mobile health applications. Items are rated on a 7-point Likert scale ranging from 1 = strongly disagree to 7 = strongly agree. Responses are aggregated according to standard scoring procedures to calculate a mean total score, with higher scores indicating greater perceived usability.
At the discharge from inpatient rehabilitation (6-8 wk post-surgery).
Mobile App Rating Scale (MARS)
Time Frame: At the discharge from inpatient rehabilitation (6-8 wk post-surgery).
The quality of the mobile health application will be assessed using the Mobile App Rating Scale (MARS). The instrument includes four domains (engagement, functionality, aesthetics, and information quality), but the outcome will be reported as a single composite score calculated as the mean of all MARS items, each rated on a 5-point Likert scale. Total scores range from 1 to 5, with higher scores indicating better perceived app quality.
At the discharge from inpatient rehabilitation (6-8 wk post-surgery).
Perceived hedonic and pragmatic quality (AttrakDiff)
Time Frame: At the discharge from inpatient rehabilitation (6-8 wk post-surgery).
The AttrakDiff questionnaire assesses user experience of the digital intervention, including pragmatic quality (usability), hedonic quality (stimulation and identification), and overall attractiveness. Items are rated on a 7-point semantic differential scale ranging from -3 to +3. Scores are aggregated according to standard procedures to calculate overall and subscale scores, with higher values indicating more positive user experience.
At the discharge from inpatient rehabilitation (6-8 wk post-surgery).
Affinity for Technology Interaction (ATI)
Time Frame: At the discharge from inpatient rehabilitation (6-8 wk post-surgery).
The Affinity for Technology Interaction (ATI) Scale will be used to measure individuals' tendency to interact with and use technology in daily life. The scale consists of multiple items rated on a 6-point Likert scale (1 = completely disagree to 6 = completely agree). A mean total score will be calculated as the outcome measure. Higher scores indicate greater affinity for technology interaction.
At the discharge from inpatient rehabilitation (6-8 wk post-surgery).
Structured interviews
Time Frame: At the discharge from inpatient rehabilitation (6-8 wk post-surgery).
Structured interviews will be conducted to qualitatively explore patient experiences, acceptability, usability, and perceived usefulness of the digitally supported intervention throughout the perioperative pathway. Interview responses will be analyzed descriptively to identify common themes related to patient experiences with the intervention. No numerical score will be calculated.
At the discharge from inpatient rehabilitation (6-8 wk post-surgery).

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Daniela Wurhofer, Dr., Ludwig Boltzmann Institute for Digital Health and Prevention

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

May 20, 2026

Primary Completion (Estimated)

April 1, 2027

Study Completion (Estimated)

May 1, 2027

Study Registration Dates

First Submitted

April 16, 2026

First Submitted That Met QC Criteria

May 29, 2026

First Posted (Actual)

June 2, 2026

Study Record Updates

Last Update Posted (Actual)

June 2, 2026

Last Update Submitted That Met QC Criteria

May 29, 2026

Last Verified

May 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

Individual participant data (IPD) will not be shared in order to protect participant confidentiality and in accordance with applicable data protection regulations, including the General Data Protection Regulation (GDPR). Only aggregated and fully anonymized data will be reported in scientific publications and presentations. No individual-level data will be made publicly available. Access to underlying data may be considered upon reasonable request and subject to institutional, ethical, and legal approval.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Total Knee Replacement

Clinical Trials on Usual Care Group

Subscribe